Explore / Clinical trial
Clinical trial

FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression

Drew CummingCompletedPhase 2Started Nov 12, 202420 enrolledUnited StatesNCT06620042

Abstract

This is a prospective open-label observational study of patients with treatment resistant bipolar depression referred for intravenous ketamine, with an interventional component of fMRI.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

bipolar depressionbipolar disorderbipolarBipolar DepressionTreatment Resistant Bipolar Depression

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.